- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2350
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Genomic NGFBvariation and multiple sclerosis in a case control study ; volume:9 ; number:1 ; day:08 ; month:12 ; year:2008 ; pages:1-8 ; date:12.2008
BMC medical genetics ; 9, Heft 1 (08.12.2008), 1-8, 12.2008
- Urheber
-
Akkad, Denis A.
- Beteiligte Personen und Organisationen
- DOI
-
10.1186/1471-2350-9-107
- URN
-
urn:nbn:de:1111-2016021835296
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.7250, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Akkad, Denis A.
- Kruse, Niels
- Arning, Larissa
- Gold, Ralf
- Epplen, Jörg T.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Multiple Sklerose - zwischen Grundlagenforschung und klinischer Anwendung
Efficacy and Safety of Multiple Sclerosis Drugs Approved Since 2018 and Future Developments
CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient
CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient
Dietary fatty acids and susceptibility to multiple sclerosis
Predictors for therapy response to intrathecal corticosteroid therapy in Multiple Sclerosis
Krankheitsmodifizierende Therapie der sekundär progredienten Multiplen Sklerose
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Microstructural White Matter Alterations in Cognitively Impaired Patients at Early Stages of Multiple Sclerosis
Ausgewählte Aspekte von Lebenssituation und medizinischer Versorgung Multiple Sklerose Betroffener in Deutschland
Siponimod treatment response shows partial BDNF dependency in multiple sclerosis models
Multiple sclerosis disease activity and disability following cessation of Fingolimod for pregnancy
Multiple Sklerose - zwischen Grundlagenforschung und klinischer Anwendung
Efficacy and Safety of Multiple Sclerosis Drugs Approved Since 2018 and Future Developments
CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient
CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient
Dietary fatty acids and susceptibility to multiple sclerosis
Predictors for therapy response to intrathecal corticosteroid therapy in Multiple Sclerosis
Krankheitsmodifizierende Therapie der sekundär progredienten Multiplen Sklerose
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Microstructural White Matter Alterations in Cognitively Impaired Patients at Early Stages of Multiple Sclerosis
Ausgewählte Aspekte von Lebenssituation und medizinischer Versorgung Multiple Sklerose Betroffener in Deutschland
Siponimod treatment response shows partial BDNF dependency in multiple sclerosis models
Multiple sclerosis disease activity and disability following cessation of Fingolimod for pregnancy
Multiple Sklerose - zwischen Grundlagenforschung und klinischer Anwendung
Efficacy and Safety of Multiple Sclerosis Drugs Approved Since 2018 and Future Developments
CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient
CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient
Dietary fatty acids and susceptibility to multiple sclerosis
Predictors for therapy response to intrathecal corticosteroid therapy in Multiple Sclerosis
Krankheitsmodifizierende Therapie der sekundär progredienten Multiplen Sklerose
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Microstructural White Matter Alterations in Cognitively Impaired Patients at Early Stages of Multiple Sclerosis
Ausgewählte Aspekte von Lebenssituation und medizinischer Versorgung Multiple Sklerose Betroffener in Deutschland
Siponimod treatment response shows partial BDNF dependency in multiple sclerosis models